Answer
During Duodopa treatment for any indication, patients and providers should monitor regularly for melanomas, ideally with periodic skin examinations by appropriately qualified individuals, such as dermatologists.
Sources for this answer
- Duodopa intestinal gelAbbVie Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 22Document updated
Sources checked